FFW
TEVA icon

Fusion Family Wealth’s Teva Pharmaceuticals TEVA Stock Holding History

Fusion Family Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-608
Closed -$11K – 304
2017
Q3 		$11K Buy
+608
New +$13.7K ﹤0.01% 149
2017
Q2 		– Sell
-405
Closed -$13K – 317
2017
Q1 		$13K Hold
405
– – ﹤0.01% 194
2016
Q4 		$13K Buy
+405
New +$16.2K 0.01% 226

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Fusion Family Wealth's TEVA Position: Q4 2017 in Review

Fusion Family Wealth sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 608 shares — an estimated $11K sold.

Fusion Family Wealth first reported a position in TEVA in Q4 2016 and held it in 3 quarters. The position peaked at $13K in Q1 2017. 507 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Fusion Family Wealth reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Fusion Family Wealth sold 608 Teva Pharmaceuticals shares in Q4 2017, an estimated $11K.
  • Fusion Family Wealth first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 3 quarters.
  • Fusion Family Wealth's Teva Pharmaceuticals position peaked at $13K in Q1 2017.
  • 507 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Fusion Family Wealth's 13F filing for Q4 2017, filed 6 Feb 2018.